QA: DR Tattoff INC in us_health_services/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001294157_2014_DR_Tattoff_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning No stock price available subcommand.plot {}
warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.2408904206908866, 'aggregate_val': 11032409, 'exp_sum': 14533355, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 2365514, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 7200290, 'DepreciationDepletionAndAmortization': 542695, 'SellingAndMarketingExpense': 592737, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 3832119}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0001294157, DR Tattoff INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 251,270
2 AssetsCurrent 594,638
3 PropertyPlantAndEquipment 2,050,287
4 remainder_Assets 0
5 LongTermLiabilities 583,844
6 LiabilitiesCurrent 6,030,115
7 remainder_Liabilities 295,227
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 2,911,503
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 397,413
14 SellingAndMarketingExpense 776,064
15 ResearchAndDevelopmentExpense 0
16 remainder_Expenses 3,941,713
17 remainder_Revenues 3,654,600
18 remainder_NetIncome 71,550
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,896,195
1 Liabilities 6,909,186
2 Expenses 8,026,693
3 Revenues 3,654,600
4 StockholdersEquity -4,012,991
5 NetIncome -4,300,543
6 ComprehensiveNetIncome -4,300,543
7 BaseVar 10,779,112
8 EconomicCapitalRatio -3.15

Edgar->Model Mapping

Feature Distribution

Change over Time